Company
ArcoScreen SA
Incorporated
July 2021
Headquarter
Lausanne
Support
Improving drug discovery through patient cell-screening.
ArcoScreen SA is an EPFL spin off founded in July 2021 in Lausanne. We are specialized in the development of tools for G protein coupled receptors (GPCRs) drug discovery. Our revolutionary technology enables the prediction of a drugs efficacy rapidly and early in the drug discovery process (lead optimization and mode of action identification) before expensive clinical trials directly on primary cells.
Our mission is to revolutionize drug discovery to improve patients lives.
